Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis
Abstract Background and aims The existing evidence has indicated that hyperthermia ablation (HA) and HA combined with transarterial chemoembolization (HATACE) are the optimal alternative to surgical resection for patients with hepatocellular carcinoma (HCC) in the COVID‐19 crisis. However, the evide...
Guardado en:
Autores principales: | Zheng Li, Qiang Li, Xiaohu Wang, Weiqiang Chen, Xiaodong Jin, Xinguo Liu, Fei Ye, Zhongying Dai, Xiaogang Zheng, Ping Li, Chao Sun, Xiongxiong Liu, Qiuning Zhang, Hongtao Luo, Ruifeng Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0111e4d5fc90471880ca6ac191ad8656 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
por: Joel Ferreira-Silva, et al.
Publicado: (2021) -
Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
por: Amira Isaac, et al.
Publicado: (2021) -
Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure
por: Constantine Frangakis, et al.
Publicado: (2021) -
Prediction of Early Treatment Response to Initial Conventional Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma by Machine-Learning Model Based on Computed Tomography
por: Dong Z, et al.
Publicado: (2021) -
Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices
por: Ziwen Tao, et al.
Publicado: (2021)